Blog     Careers     About Us     Bill Pay     Patient Portal     QOPI Re-Certification     

Alan Langerak, MD Alan Langerak, MD

Alan Langerak, MD

Medical Oncology and Hematology

Patient Portal

Locations:

Prescott Valley

Prescott Valley

3188 N. Windsong Dr., Suite A
Prescott Valley, AZ 86314
View Map
Call: 928-775-9430
Fax: 928-775-9431
Prescott

Prescott

1100 Gail Gardner Way
Prescott, AZ 86305
View Map
Call: 928-775-9430
Fax: 928-775-9431

Education & Credentials

College

Arizona State University

Medical School

University of Arizona

Internship

University of Arizona

Residency

University of Arizona

Fellowship

University of Arizona and Arizona Cancer Center

Board Certification

Medical Oncology and Hematology

Affiliations

  • American Society of Clinical Oncology                          
  • American Society of Hematology

Languages

English

Biography

Dr. Langerak’s expertise includes multiple myeloma, lymphoma, breast, pancreatic, stomach, colon, lung, kidney, ovarian, uterine, testicular, bladder, and prostate cancers, as well as benign hematological problems. He received his undergraduate degree from Arizona State University where he graduated summa cum laude with a degree in biology. He received his medical degree from the University of Arizona College of Medicine. He completed an internship and residency in internal medicine as well as a fellowship in Hematology and Oncology at the University of Arizona College of Medicine and Arizona Cancer Center. Dr. Langerak is board certified in hematology and medical oncology by the American Board of Internal Medicine. He is a member of the American Society of Clinical Oncology, American Society of Hematology, and the American College of Physicians. Additionally, he is co-author of a handbook entitled "Chemotherapy Regimens and Cancer Care".

Personal

Dr. Langerak is married to Kelly Langerak, PharmD. They have 2 grown children, Andrew and Madison. They have 3 golden retrievers, Penny, Blue, and Gus.

FOLLOW US:

AZ Oncology

Subscribe to the latest in cancer news — delivered to your inbox.